can you take tirzepatide more than once a week Dosing Tirzepatide Dosing Chart: Weekly Guide

2026 is the year in which the long-term themes, the true drivers of sustainable success for the burgeoning landscape of obesity treatment, prescription medicines and beyond, become apparent

Watch doctors and researchers explain GLP-1 medications, peptide therapy, and what the latest science actually shows.

AstraZeneca Targeting $80B revenue by 2030 20+ new medicines planned this decade Strong wins in oncology & rare diseases 4

PlexusDx provides compounded semaglutide injection therapy starting at $149/month with personalized genetic testing to optimize your cardiovascula

Explore GLP-1 medications like Ozempic and Wegovy

Study: TripleHormone Receptor Agonist Retatrutide for Obesity (Phase 2 Trial, NEJM) Drug: Retatrutide a triple agonist (GLP-1, GIP, and glucagon receptors) Key Findings: Up to 28.7% mean weight loss at higher doses Marked improvements in insulin sensitivity and cardiometabolic risk factors Weight loss approaching outcomes seen with bariatric surgery, without surgery What makes Retatrutide unique is its triple-hormone mechanism, simultaneously targeting appetite regulation, energy expenditure, and glucose metabolism